Foscarnet and AZT resistance. New drug 1263W94 effective against ganciclovir-resistant cytomegalovirus in vitro. Monoclonal CMV antibody therapy not effective for retinitis. See p. 22-23. Responding to CMV neurologic infections.
Opportunistic infections update.
See p. 16. Guidelines on cidofovir. The status of CMV viral load testing. See p. 11-14. Patterns in CMV pneumonia.